BioCentury
ARTICLE | Clinical News

Photofrin porfimer sodium: SPA received

January 20, 2014 8:00 AM UTC

Pinnacle received an SPA from FDA for a Phase III trial to evaluate Photofrin to treat unresectable advanced perihilar cholangiocarcinoma Bismuth type III/IV. The company expects to begin the trial this half. ...